Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis

[1] Lovell RM(2012)Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis Clin Gastroenterol Hepatol 10 712-721.e4

[2] Ford AC(2017)Rome criteria and a diagnostic approach to irritable bowel syndrome J Clin Med 6 99-275

[3] Lacy B(2004)Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin Am J Reprod Immunol 52 267-1396

[4] Patel N(2008)Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: Findings from a national case-control study - Part 2 BJOG An Int J Obstet Gynaecol 115 1392-912

[5] Kempuraj D(2015)The risk of irritable bowel syndrome in patients with endometriosis during a 5-year follow-up: a nationwide population-based cohort study Int J Colorectal Dis 30 907-14

[6] Papadopoulou N(2018)Characteristics of endometriosis: A case-cohort study showing elevated IgG titers against the TSH receptor (TRAb) and mental comorbidity Eur J Obstet Gynecol Reprod Biol 231 8-30

[7] Stanford EJ(1987)Quantitative methods in the review of epidemiologic literature Epidemiol Rev 9 1-1558

[8] Christodoulou S(2002)Quantifying heterogeneity in a meta-analysis Stat Med 21 1539-716

[9] Madhappan B(2009)Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement PLoS Med 6 e1000097-71

[10] Sant GR(2003)Methodological index for non-randomized studies (Minors): Development and validation of a new instrument ANZ J Surg 73 712-164

[1] Lovell RM(2012)Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis Clin Gastroenterol Hepatol 10 712-721.e4

[2] Ford AC(2017)Rome criteria and a diagnostic approach to irritable bowel syndrome J Clin Med 6 99-275

[3] Lacy B(2004)Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin Am J Reprod Immunol 52 267-1396

[4] Patel N(2008)Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: Findings from a national case-control study - Part 2 BJOG An Int J Obstet Gynaecol 115 1392-912

[5] Kempuraj D(2015)The risk of irritable bowel syndrome in patients with endometriosis during a 5-year follow-up: a nationwide population-based cohort study Int J Colorectal Dis 30 907-14

[6] Papadopoulou N(2018)Characteristics of endometriosis: A case-cohort study showing elevated IgG titers against the TSH receptor (TRAb) and mental comorbidity Eur J Obstet Gynecol Reprod Biol 231 8-30

[7] Stanford EJ(1987)Quantitative methods in the review of epidemiologic literature Epidemiol Rev 9 1-1558

[8] Christodoulou S(2002)Quantifying heterogeneity in a meta-analysis Stat Med 21 1539-716

[9] Madhappan B(2009)Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement PLoS Med 6 e1000097-71

[10] Sant GR(2003)Methodological index for non-randomized studies (Minors): Development and validation of a new instrument ANZ J Surg 73 712-164